278 related articles for article (PubMed ID: 17253535)
1. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.
Lirussi F; Azzalini L; Orando S; Orlando R; Angelico F
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD004996. PubMed ID: 17253535
[TBL] [Abstract][Full Text] [Related]
2. Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.
Orlando R; Azzalini L; Orando S; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005160. PubMed ID: 17253541
[TBL] [Abstract][Full Text] [Related]
3. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
4. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
[TBL] [Abstract][Full Text] [Related]
5. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.
Lirussi F; Mastropasqua E; Orando S; Orlando R
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD005165. PubMed ID: 17253543
[TBL] [Abstract][Full Text] [Related]
6. Bariatric surgery for non-alcoholic steatohepatitis in obese patients.
Chavez-Tapia NC; Tellez-Avila FI; Barrientos-Gutierrez T; Mendez-Sanchez N; Lizardi-Cervera J; Uribe M
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD007340. PubMed ID: 20091629
[TBL] [Abstract][Full Text] [Related]
7. Herbal medicines for fatty liver diseases.
Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP
Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant supplements for liver diseases.
Bjelakovic G; Gluud LL; Nikolova D; Bjelakovic M; Nagorni A; Gluud C
Cochrane Database Syst Rev; 2011 Mar; (3):CD007749. PubMed ID: 21412909
[TBL] [Abstract][Full Text] [Related]
9. Propylthiouracil for alcoholic liver disease.
Rambaldi A; Gluud C
Cochrane Database Syst Rev; 2005 Oct; (4):CD002800. PubMed ID: 16235302
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants for preventing and reducing muscle soreness after exercise.
Ranchordas MK; Rogerson D; Soltani H; Costello JT
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD009789. PubMed ID: 29238948
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticosteroids for primary biliary cirrhosis.
Prince M; Christensen E; Gluud C
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003778. PubMed ID: 15846681
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil for alcoholic liver disease.
Fede G; Germani G; Gluud C; Gurusamy KS; Burroughs AK
Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD002800. PubMed ID: 21678335
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2012 Nov; 11():CD000254. PubMed ID: 23152201
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis.
Nakade Y; Murotani K; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Ito K; Fukuzawa Y; Yoneda M
Hepatol Res; 2017 Dec; 47(13):1417-1428. PubMed ID: 28257594
[TBL] [Abstract][Full Text] [Related]
17. Nitazoxanide for chronic hepatitis C.
Nikolova K; Gluud C; Grevstad B; Jakobsen JC
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
[TBL] [Abstract][Full Text] [Related]
18. Bezafibrate for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D supplementation for chronic liver diseases in adults.
Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients?
Musso G; Anty R; Petta S
Curr Pharm Des; 2013; 19(29):5297-313. PubMed ID: 23394094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
